Combination of a DPP IV inhibitor and an antiobesity or appetite regulating agent

Details for Australian Patent Application No. 2009201408 (hide)

Owner Novartis AG

Inventors Holmes, David Grenville

Agent Davies Collison Cave

Pub. Number AU-A-2009201408

Parent 2004290896

Filing date 9 April 2009

Wipo publication date 7 May 2009

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

30 April 2009 Complete Application Filed

7 May 2009 Application Open to Public Inspection

  Published as AU-A-2009201408

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201409-Roofing screw (three piece)

2009201407-Chemical compounds